Neuroleptics Market - Global Outlook and Forecast 2022-2028

January 2022 | 77 pages | ID: NA4448A8DD2DEN
Market Monitor Global

Abstracts

Neuroleptics are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psychotic disorders. Antipsychotics are usually effective in relieving symptoms of psychosis in the short term.

This report contains market size and forecasts of Neuroleptics in global, including the following market information:

Global Neuroleptics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Neuroleptics Market Sales, 2017-2022, 2023-2028, (K MT)

Global top five Neuroleptics companies in 2021 (%)

The global Neuroleptics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

First Generation Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Neuroleptics include Johnson & Johnson, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, GSK and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neuroleptics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Neuroleptics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Neuroleptics Market Segment Percentages, by Type, 2021 (%)

• First Generation
• Second Generation
• Third Generation

Global Neuroleptics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Neuroleptics Market Segment Percentages, by Application, 2021 (%)

• Schizophrenia
• Bipolar Disorder
• Unipolar Depression
• Dementia
• Others

Global Neuroleptics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Neuroleptics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Neuroleptics revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Neuroleptics revenues share in global market, 2021 (%)

Key companies Neuroleptics sales in global market, 2017-2022 (Estimated), (K MT)

Key companies Neuroleptics sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson & Johnson
• Pfizer
• Eli Lilly
• Bristol-Myers Squibb
• AstraZeneca
• GSK
• Allergan

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Neuroleptics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Neuroleptics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NEUROLEPTICS OVERALL MARKET SIZE

2.1 Global Neuroleptics Market Size: 2021 VS 2028
2.2 Global Neuroleptics Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Neuroleptics Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Neuroleptics Players in Global Market
3.2 Top Global Neuroleptics Companies Ranked by Revenue
3.3 Global Neuroleptics Revenue by Companies
3.4 Global Neuroleptics Sales by Companies
3.5 Global Neuroleptics Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Neuroleptics Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Neuroleptics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neuroleptics Players in Global Market
  3.8.1 List of Global Tier 1 Neuroleptics Companies
  3.8.2 List of Global Tier 2 and Tier 3 Neuroleptics Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Neuroleptics Market Size Markets, 2021 & 2028
  4.1.2 First Generation
  4.1.3 Second Generation
  4.1.4 Third Generation
4.2 By Type - Global Neuroleptics Revenue & Forecasts
  4.2.1 By Type - Global Neuroleptics Revenue, 2017-2022
  4.2.2 By Type - Global Neuroleptics Revenue, 2023-2028
  4.2.3 By Type - Global Neuroleptics Revenue Market Share, 2017-2028
4.3 By Type - Global Neuroleptics Sales & Forecasts
  4.3.1 By Type - Global Neuroleptics Sales, 2017-2022
  4.3.2 By Type - Global Neuroleptics Sales, 2023-2028
  4.3.3 By Type - Global Neuroleptics Sales Market Share, 2017-2028
4.4 By Type - Global Neuroleptics Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Neuroleptics Market Size, 2021 & 2028
  5.1.2 Schizophrenia
  5.1.3 Bipolar Disorder
  5.1.4 Unipolar Depression
  5.1.5 Dementia
  5.1.6 Others
5.2 By Application - Global Neuroleptics Revenue & Forecasts
  5.2.1 By Application - Global Neuroleptics Revenue, 2017-2022
  5.2.2 By Application - Global Neuroleptics Revenue, 2023-2028
  5.2.3 By Application - Global Neuroleptics Revenue Market Share, 2017-2028
5.3 By Application - Global Neuroleptics Sales & Forecasts
  5.3.1 By Application - Global Neuroleptics Sales, 2017-2022
  5.3.2 By Application - Global Neuroleptics Sales, 2023-2028
  5.3.3 By Application - Global Neuroleptics Sales Market Share, 2017-2028
5.4 By Application - Global Neuroleptics Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Neuroleptics Market Size, 2021 & 2028
6.2 By Region - Global Neuroleptics Revenue & Forecasts
  6.2.1 By Region - Global Neuroleptics Revenue, 2017-2022
  6.2.2 By Region - Global Neuroleptics Revenue, 2023-2028
  6.2.3 By Region - Global Neuroleptics Revenue Market Share, 2017-2028
6.3 By Region - Global Neuroleptics Sales & Forecasts
  6.3.1 By Region - Global Neuroleptics Sales, 2017-2022
  6.3.2 By Region - Global Neuroleptics Sales, 2023-2028
  6.3.3 By Region - Global Neuroleptics Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Neuroleptics Revenue, 2017-2028
  6.4.2 By Country - North America Neuroleptics Sales, 2017-2028
  6.4.3 US Neuroleptics Market Size, 2017-2028
  6.4.4 Canada Neuroleptics Market Size, 2017-2028
  6.4.5 Mexico Neuroleptics Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Neuroleptics Revenue, 2017-2028
  6.5.2 By Country - Europe Neuroleptics Sales, 2017-2028
  6.5.3 Germany Neuroleptics Market Size, 2017-2028
  6.5.4 France Neuroleptics Market Size, 2017-2028
  6.5.5 U.K. Neuroleptics Market Size, 2017-2028
  6.5.6 Italy Neuroleptics Market Size, 2017-2028
  6.5.7 Russia Neuroleptics Market Size, 2017-2028
  6.5.8 Nordic Countries Neuroleptics Market Size, 2017-2028
  6.5.9 Benelux Neuroleptics Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Neuroleptics Revenue, 2017-2028
  6.6.2 By Region - Asia Neuroleptics Sales, 2017-2028
  6.6.3 China Neuroleptics Market Size, 2017-2028
  6.6.4 Japan Neuroleptics Market Size, 2017-2028
  6.6.5 South Korea Neuroleptics Market Size, 2017-2028
  6.6.6 Southeast Asia Neuroleptics Market Size, 2017-2028
  6.6.7 India Neuroleptics Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Neuroleptics Revenue, 2017-2028
  6.7.2 By Country - South America Neuroleptics Sales, 2017-2028
  6.7.3 Brazil Neuroleptics Market Size, 2017-2028
  6.7.4 Argentina Neuroleptics Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Neuroleptics Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Neuroleptics Sales, 2017-2028
  6.8.3 Turkey Neuroleptics Market Size, 2017-2028
  6.8.4 Israel Neuroleptics Market Size, 2017-2028
  6.8.5 Saudi Arabia Neuroleptics Market Size, 2017-2028
  6.8.6 UAE Neuroleptics Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Corporate Summary
  7.1.2 Johnson & Johnson Business Overview
  7.1.3 Johnson & Johnson Neuroleptics Major Product Offerings
  7.1.4 Johnson & Johnson Neuroleptics Sales and Revenue in Global (2017-2022)
  7.1.5 Johnson & Johnson Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Neuroleptics Major Product Offerings
  7.2.4 Pfizer Neuroleptics Sales and Revenue in Global (2017-2022)
  7.2.5 Pfizer Key News
7.3 Eli Lilly
  7.3.1 Eli Lilly Corporate Summary
  7.3.2 Eli Lilly Business Overview
  7.3.3 Eli Lilly Neuroleptics Major Product Offerings
  7.3.4 Eli Lilly Neuroleptics Sales and Revenue in Global (2017-2022)
  7.3.5 Eli Lilly Key News
7.4 Bristol-Myers Squibb
  7.4.1 Bristol-Myers Squibb Corporate Summary
  7.4.2 Bristol-Myers Squibb Business Overview
  7.4.3 Bristol-Myers Squibb Neuroleptics Major Product Offerings
  7.4.4 Bristol-Myers Squibb Neuroleptics Sales and Revenue in Global (2017-2022)
  7.4.5 Bristol-Myers Squibb Key News
7.5 AstraZeneca
  7.5.1 AstraZeneca Corporate Summary
  7.5.2 AstraZeneca Business Overview
  7.5.3 AstraZeneca Neuroleptics Major Product Offerings
  7.5.4 AstraZeneca Neuroleptics Sales and Revenue in Global (2017-2022)
  7.5.5 AstraZeneca Key News
7.6 GSK
  7.6.1 GSK Corporate Summary
  7.6.2 GSK Business Overview
  7.6.3 GSK Neuroleptics Major Product Offerings
  7.6.4 GSK Neuroleptics Sales and Revenue in Global (2017-2022)
  7.6.5 GSK Key News
7.7 Allergan
  7.7.1 Allergan Corporate Summary
  7.7.2 Allergan Business Overview
  7.7.3 Allergan Neuroleptics Major Product Offerings
  7.7.4 Allergan Neuroleptics Sales and Revenue in Global (2017-2022)
  7.7.5 Allergan Key News

8 GLOBAL NEUROLEPTICS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Neuroleptics Production Capacity, 2017-2028
8.2 Neuroleptics Production Capacity of Key Manufacturers in Global Market
8.3 Global Neuroleptics Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 NEUROLEPTICS SUPPLY CHAIN ANALYSIS

10.1 Neuroleptics Industry Value Chain
10.2 Neuroleptics Upstream Market
10.3 Neuroleptics Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Neuroleptics Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Neuroleptics in Global Market
Table 2. Top Neuroleptics Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Neuroleptics Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Neuroleptics Revenue Share by Companies, 2017-2022
Table 5. Global Neuroleptics Sales by Companies, (K MT), 2017-2022
Table 6. Global Neuroleptics Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Neuroleptics Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Neuroleptics Product Type
Table 9. List of Global Tier 1 Neuroleptics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuroleptics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Neuroleptics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Neuroleptics Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Neuroleptics Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Neuroleptics Sales (K MT), 2017-2022
Table 15. By Type - Global Neuroleptics Sales (K MT), 2023-2028
Table 16. By Application – Global Neuroleptics Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Neuroleptics Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Neuroleptics Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Neuroleptics Sales (K MT), 2017-2022
Table 20. By Application - Global Neuroleptics Sales (K MT), 2023-2028
Table 21. By Region – Global Neuroleptics Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Neuroleptics Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Neuroleptics Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Neuroleptics Sales (K MT), 2017-2022
Table 25. By Region - Global Neuroleptics Sales (K MT), 2023-2028
Table 26. By Country - North America Neuroleptics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Neuroleptics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Neuroleptics Sales, (K MT), 2017-2022
Table 29. By Country - North America Neuroleptics Sales, (K MT), 2023-2028
Table 30. By Country - Europe Neuroleptics Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Neuroleptics Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Neuroleptics Sales, (K MT), 2017-2022
Table 33. By Country - Europe Neuroleptics Sales, (K MT), 2023-2028
Table 34. By Region - Asia Neuroleptics Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Neuroleptics Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Neuroleptics Sales, (K MT), 2017-2022
Table 37. By Region - Asia Neuroleptics Sales, (K MT), 2023-2028
Table 38. By Country - South America Neuroleptics Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Neuroleptics Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Neuroleptics Sales, (K MT), 2017-2022
Table 41. By Country - South America Neuroleptics Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Neuroleptics Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Neuroleptics Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Neuroleptics Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Neuroleptics Sales, (K MT), 2023-2028
Table 46. Johnson & Johnson Corporate Summary
Table 47. Johnson & Johnson Neuroleptics Product Offerings
Table 48. Johnson & Johnson Neuroleptics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Neuroleptics Product Offerings
Table 51. Pfizer Neuroleptics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Eli Lilly Corporate Summary
Table 53. Eli Lilly Neuroleptics Product Offerings
Table 54. Eli Lilly Neuroleptics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Bristol-Myers Squibb Corporate Summary
Table 56. Bristol-Myers Squibb Neuroleptics Product Offerings
Table 57. Bristol-Myers Squibb Neuroleptics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Neuroleptics Product Offerings
Table 60. AstraZeneca Neuroleptics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. GSK Corporate Summary
Table 62. GSK Neuroleptics Product Offerings
Table 63. GSK Neuroleptics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Allergan Corporate Summary
Table 65. Allergan Neuroleptics Product Offerings
Table 66. Allergan Neuroleptics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Neuroleptics Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 68. Global Neuroleptics Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Neuroleptics Production by Region, 2017-2022 (K MT)
Table 70. Global Neuroleptics Production by Region, 2023-2028 (K MT)
Table 71. Neuroleptics Market Opportunities & Trends in Global Market
Table 72. Neuroleptics Market Drivers in Global Market
Table 73. Neuroleptics Market Restraints in Global Market
Table 74. Neuroleptics Raw Materials
Table 75. Neuroleptics Raw Materials Suppliers in Global Market
Table 76. Typical Neuroleptics Downstream
Table 77. Neuroleptics Downstream Clients in Global Market
Table 78. Neuroleptics Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Neuroleptics Segment by Type
Figure 2. Neuroleptics Segment by Application
Figure 3. Global Neuroleptics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Neuroleptics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Neuroleptics Revenue, 2017-2028 (US$, Mn)
Figure 7. Neuroleptics Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Neuroleptics Revenue in 2021
Figure 9. By Type - Global Neuroleptics Sales Market Share, 2017-2028
Figure 10. By Type - Global Neuroleptics Revenue Market Share, 2017-2028
Figure 11. By Type - Global Neuroleptics Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Neuroleptics Sales Market Share, 2017-2028
Figure 13. By Application - Global Neuroleptics Revenue Market Share, 2017-2028
Figure 14. By Application - Global Neuroleptics Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Neuroleptics Sales Market Share, 2017-2028
Figure 16. By Region - Global Neuroleptics Revenue Market Share, 2017-2028
Figure 17. By Country - North America Neuroleptics Revenue Market Share, 2017-2028
Figure 18. By Country - North America Neuroleptics Sales Market Share, 2017-2028
Figure 19. US Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Neuroleptics Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Neuroleptics Sales Market Share, 2017-2028
Figure 24. Germany Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 25. France Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Neuroleptics Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Neuroleptics Sales Market Share, 2017-2028
Figure 33. China Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 37. India Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Neuroleptics Revenue Market Share, 2017-2028
Figure 39. By Country - South America Neuroleptics Sales Market Share, 2017-2028
Figure 40. Brazil Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Neuroleptics Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Neuroleptics Sales Market Share, 2017-2028
Figure 44. Turkey Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Neuroleptics Revenue, (US$, Mn), 2017-2028
Figure 48. Global Neuroleptics Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Neuroleptics by Region, 2020 VS 2027
Figure 50. Neuroleptics Industry Value Chain
Figure 51. Marketing Channels